Journal of Medicinal Chemistry p. 4125 - 4130 (1995)
Update date:2022-08-03
Topics:
Feng, Dong-Mei
Veber, Daniel F.
Connolly, Thomas M.
Condra, Cindra
Tang, Mei-Jy
Nutt, Ruth F.
The N-terminal thrombin receptor peptide H-Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-OH (1) fully activates the thrombin receptor with an EC50 of 10 μM.Structural features in the tetradecapeptide which are responsible for receptor activation have been elucidated.Agonist potency has been enhanced 1000-fold with the design of the shortened peptide H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr-NH2 (56).This analog exhibits an EC50 of 0,01 μM and is the most potent agonist for receptor activation reported to date.The monoiodinated derivative H-Ala-Phe(p-F)-Arg-Cha-HArg-Tyr(3-I)-NH2 (59) exhibits an EC50 of 0.03 μM, a level sufficient for development of a radioligand.
View MoreContact:--
Address:80G, No.1 Building, Guodu Development Mansion, No. 182 Zhaohui Road, Hangzhou City, Zhejiang Province,China.
Nanjing Zelang Medical Technology Co. Ltd
Contact:86-25-83063290/13770714480
Address:Ganjiabian 108# 01 Unit,701-702 room,Yao Hua Street,Qixia District,Nanjing,Jiangsu,China
MTT Pharma & Bio-technology Co.,Ltd(expird)
Contact:+86-21-58407925
Address:Room2019, Building C, Tomson Center, No.158, Zhang Yang Road, Shanghai, China
Changyi Xinxing Technology Development Co., Ltd.
Contact:0086-510-86651065(Time Zone:8),86651656
Address:94 Yingbinxilu WestRoad, Huangtu Town, Jiangyin City, Jiangsu, China
website:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
Doi:10.1021/ol300709u
(2012)Doi:10.1134/S1070428012030104
(2012)Doi:10.1016/j.bmc.2012.02.003
(2012)Doi:10.1002/adsc.201100789
(2012)Doi:10.1055/s-0031-1289680
(2012)Doi:10.1021/ja302765m
(2012)
